Navigation Links
LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin
Date:11/9/2008

LegalView informed its readers of serious drug reactions and fatalities, which have hit record high numbers due partially to a blood thinner known as Heparin. The drug, from Baxter Healthcare, was found to be tainted and administered to thousands of patients.

Denver (PRWEB) November 9, 2008 -- LegalView.com, the number one legal resource available on the Web, recently announced record high numbers of serious drug reactions and fatalities among Americans, according to data gathered by the watchdog group the Institute for Safe Medication Practices (ISMP). The Associated Press reported the research on October 22, 2008, which found that the U.S. Food and Drug Administration (FDA) received nearly 21,000 reports of incidents involving severe drug reactions, with close to 23 percent of those resulting in death. The record high was in part due to a blood thinner known as Baxter Heparin, which was found to be tainted. Patients who may have been subject to the Heparin side effects should consider consulting a pharmaceutical law firm, which will likely be able to provide insightful details as to the development of any potential Heparin lawsuit.

Baxter Healthcare Corporation first received approval for Heparin in 1972 and the drug is used as a blood thinner in surgeries and procedures ranging from dialysis to heart surgery. It is used to prevent blood clots from developing, which can be fatal among patients. The drug is derived from the lining of pig intestines and has been used in millions of patients beginning as early as the 1930s. However, at the end of 2007, nearly 350 reports of serious side effects from patients began to surface. It was soon discovered that a batch of tainted Heparin had made its way into hospitals across the country from China. The tainted drug set off an international investigation with tensions between China and the U.S. running high.

As headlines grew regarding the investigation, thousands of patients were still at risk for the possible Heparin dangers. It is imperative that patients who may have received Heparin during a medical procedure contact an experienced pharmaceutical attorney to explore the potential for a Heparin class action lawsuit, which may offer monetary compensation for the damages that might have been caused by the tainted blood thinner.

In addition to reporting information on the tainted Heparin, LegalView also offers information on a range of other topics, all of which have recently been re-launched to offer victims of legal issues the most up-to-date news and information. For example, LegalView offers information portals on topics such as the rare, but serious mesothelioma cancer as well as information on traumatic brain injuries. LegalView also offers coverage on several other pharmaceutical drugs including Avandia.

Mesothelioma is a serious and rare cancer that is becoming more common among the U.S. elderly population. Mesothelioma cancer is caused by the exposure of an individual to asbestos fibers and dust. It takes years and, in most cases, decades before symptoms of mesothelioma become apparent. Even then the mesothelioma symptoms are often misdiagnosed for other similar conditions, which negatively effects an individual's treatment success.

Another of LegalView's most recently re-launched information portals is that of the traumatic brain injury (TBI) site. More than 5 million Americans currently suffer from TBI, and thousands, if not millions, of those victims go undiagnosed, leading to a potentially severe or fatal outcome. The number of TBI victims is also growing as thousands of U.S. soldiers returning from the war in Iraq are plagued by traumatic brain injury.

For information on other controversial pharmaceuticals, individuals can use the LegalView library to find the latest on unsafe drugs, such as the type 2 diabetes drug Avandia. Avandia, from GlaxoSmithKline, has been prescribed to millions of patients as an anti-diabetic therapy that uses an individual's natural insulin to regulate blood sugar levels to avoid diabetic shock. However, within the last couple of years, Avandia has been linked to heart failure and heart damage as well as bone fractures/breaks and early on-set osteoporosis. Those who have consumed Avandia and may suffer from one of these risks should consult a medical professional immediately. Additionally, contacting an experienced Avandia attorney may also provide assistance to an injured person.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1566244.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
Breaking Medicine Technology: